HESI is actively exploring new ways to support the global health community in response to COVID-19. If you have specific suggestions as to how HESI can best leverage its expertise and networks, please contact us at firstname.lastname@example.org with the subject header “COVID-Support.”
HESI has also compiled selected COVID-19 information sources. The resources provided are offered as links to publicly accessible information from public (government, academic, clinical, and NGO) sources. Information is changing daily and we will do our best to update with new resource links as we are made aware of them. Click here to see the full resource page.
Information on how to connect to the meeting and the agenda will be available on the website soon. Presentations will be recorded and made available after the meeting.
For more information about the Botanical Safety Consortium, including how to join this exciting group, please visit botanicalsafetyconsortium.org or email Connie Mitchell (email@example.com) or Michelle Embry (firstname.lastname@example.org).
HESI has been closely monitoring developments pertaining to the coronavirus (COVID-19) pandemic. Given the uncertainty surrounding the pandemic, coupled with advisories from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), we have made the decision to move the 2020 HESI Annual Meeting to a virtual meeting format. Please continue to hold 9-10 June 2020 on your calendars! On those dates, we will host selected, live online presentations and discussion sessions to allow access to some of the content we had planned for our in-person meeting. Updates on timing and content will be posted here as they become available.
The last three weeks have been unlike any other – for all of us. In many ways, both bad and good, this time has drawn us closer together as a global community of scientists, citizens, and colleagues. As are all of you, we are actively following the rapidly changing health messaging and research. We have included a page with links to available technical resources on our site. Undoubtedly, the publicly accessible scientific approaches to drug and vaccine safety, risk assessment, epidemiology, and exposure evaluation that HESI has developed and will develop will be critical foundations to addressing this global pandemic in the near to long term. I am actively encouraging all of our partners and programs to consider whether there are new opportunities to leverage our expertise and resources to support global efforts to combat COVID-19. If you have suggestions please don’t hesitate to contact me.
I wish all of you good health and give a special thanks to those who are on the front lines of combating this virus. Take care and stay in touch.
Syril D. Pettit, DrPH, MEM
HESI Executive Director